Loading…
We use essential cookies (authentication, your saved goals/stack) by default. With your permission we'll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more
Head-to-head evidence comparison — which supplement is right for you?
Ceramides and Saccharomyces Boulardii are closely matched across evidence, studies, and safety.
Verdict
Mostly mechanism / observational
2 of 2 studies with measurable effects showed benefit.
Top outcomes
Verdict
Likely helps
13 of 15 studies with measurable effects showed benefit.
Top outcomes
Shared outcomes (1)
Outcomes where both Ceramides and Saccharomyces Boulardii have evidence — compare verdict strength side-by-side.
350mg wheat-derived ceramides or 30-40mg glycosphingolipids daily
Once daily with food
Wheat-derived phytoceramides (Ceramide-PCD)
250-500mg (5-10 billion CFU) daily
With or without food, At least 2 hours away from antifungals
Capsules (lyophilized)
4-8 weeks
8-12 weeks
4-8 weeks
During use
1-3 days
1-2 weeks
Ceramides and depression: A systematic review
Journal of affective disorders (2017) · Systematic review · n=14
Pharmacotherapy targeting ceramide metabolism may be a novel treatment option for depression.
Effect of oral intake of phytoceramides on skin hydration: A systematic review and meta-analysis of clinical studies
Journal of Cosmetic Dermatology (2021) · Meta analysis · n=542
Oral phytoceramides significantly increased skin hydration measured by corneometry
Oral supplementation with plant-derived ceramides improves skin barrier function and reduces skin dryness: A randomized, double-blind, placebo-controlled trial
Journal of the European Academy of Dermatology and Venereology (2017) · Rct · n=66
Skin hydration was significantly improved after 60 days of phytoceramide supplementation
Efficacy and safety of Saccharomyces boulardii as an adjuvant therapy for the eradication of Helicobacter pylori: a meta-analysis
Frontiers in cellular and infection microbiology (2025) · Meta analysis · n=5036
S. boulardii supplementation in traditional eradication therapy significantly improves the H. pylori eradication rate and reduces the total adverse effects and incidence of diarrhea, bloating, constipation, and nausea.
Probiotics for treating acute infectious diarrhoea
The Cochrane database of systematic reviews (2020) · Meta analysis · n=12127
Effect size was similar in the sensitivity analysis and marked heterogeneity persisted.
The use of probiotics and prebiotics in decolonizing pathogenic bacteria from the gut; a systematic review and meta-analysis of clinical outcomes
Gut microbes (2024) · Meta analysis · n=2871
This review aims to analyze available evidence from human-controlled trials to determine the effect size of probiotic interventions in decolonizing AMR pathogenic bacteria from the gut.
Based on multiple meta-analyses showing 1.1-1.6 day reduction in diarrhea duration. Effect size appears to plateau at standard therapeutic doses. Limited data on doses above 20 billion CFU.
AI-estimated from published studies. Interpret as directional guidance.
Both Ceramides and Saccharomyces Boulardii are closely matched — the best choice depends on your specific health goals.
No known interactions between Ceramides and Saccharomyces Boulardii have been documented in our database. However, always consult a healthcare provider before combining supplements.